Skip to NavigationSkip to content

News

0
Scottish Medicines Consortium approves Bayer’s Kerendia for NHS Scotland
The Scottish Medicines Consortium (SMC) has given the green light to Bayer’s Kerendia (finerenone), a chronic kidney disease (CKD) drug for the...
0
GSK’s two new cancer drugs look promising
GlaxoSmithKline (GSK) appear to be making some positive progress in their oncology department, with drugs for both myelofibrosis and endometrial...
0
AstraZeneca and Merck launch prostate cancer awareness campaign
AstraZeneca and Merck have announced their collaborative prostate cancer awareness campaign, which has just launched in the US and Canada. The...
0
FDA grants approval to WISE for neuromonitoring cortical strip
WISE, a medical equipment manufacturer based in Italy, has obtained FDA approval for its single-use medical device WISE Cortical Strip (WCS), used...
>> More News Stories

Features

Veeva la Vida: A Roundup of the R&D and Quality Summit 2022

Pharmafocus journalists Ana Ovey and Lina Adams made their way to Zurich for Veeva’s annual R&D and Quality Summit 2022. Here...

>> More Features
>> More News Stories